Quantitative clinical radiobiology.
Based on a series of recent papers, a status is given of our current ability to quantify the radiobiology of human tumors and normal tissues. Progress has been made in the methods of analysis. This includes the introduction of 'direct' (maximum likelihood) analysis, incorporation of latent-time in the analyses, and statistical approaches to allow for the many factors of importance in predicting tumor-control probability or normal-tissue complications. Quantitative clinical radiobiology of normal tissues is reviewed with emphasis on fractionation sensitivity, repair kinetics, regeneration, latency, and the steepness of dose-response curves. In addition, combined modality treatment, functional endpoints, and the search for a correlation between the occurrence of different endpoints in the same individual are discussed. For tumors, quantitative analyses of fractionation sensitivity, repair kinetics, reoxygenation, and regeneration are reviewed. Other factors influencing local control are: tumor volume, histopathologic differentiation and hemoglobin concentration. Also, the steepness of the dose-response curve for tumors is discussed. Radiobiological strategies for improving radiotherapy are discussed with emphasis on non-standard fractionation and individualization of treatment schedules.
Bentzen
S M
SM
Danish Cancer Society, Department of Experimental Clinical Oncology, Aarhus.
D000818:Animals; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D015233:Models, Statistical; D009369:Neoplasms / Q000532:radiotherapy*; D011853:Radiobiology / Q000592:standards*; D011878:Radiotherapy / Q000592:standards; D011879:Radiotherapy Dosage; D014022:Tissue Survival / Q000528:radiation effects